Table 1.
Baseline risk characteristics of female and male cohorts
| Risk variable | Females (n = 474) | Males (n = 316) |
|---|---|---|
| Age, years a | 49 (44–54) | 49 (44–53) |
| BMI, kg/m2b | 26.6 ± 1.9 | 28.1 ± 1.7 |
| Systolic blood pressure, mmHg b | 125 ± 6 | 128 ± 5 |
| Diastolic blood pressure, mmHg | 82 ± 9 | 84 ± 9 |
| Total cholesterol: HDL ratio a | 3.2 (2.7–4.0) | 4.4 (3.6–5.7) |
| Triglycerides, mmol/l b,c | 1.24 ± 0.27 | 1.87 ± 0.47 |
| Family history of cardiovascular disease | 98 (20.7) | 66 (20.9) |
| Current smoker | 46 (9.7) | 52 (16.5) |
| Prescribed antihypertensive medication | 24 (5.1) | 26 (8.2) |
| QRISK2, % b | 2.3 ± 0.9 | 5.8 ± 1.9 |
| Framingham Lipids, % b | 2.6 ± 0.7 | 8.2 ± 2.1 |
| Framingham BMI, % b | 4.8 ± 1.2 | 10.7 ± 2.4 |
| JBS2, % a | 5 (2–8) | 11 (7–17) |
Data expressed as means ± SD with discrete data represented as numbers with percentage of sex in brackets.
a
Data not normally distributed after log transformation, median and interquartile range reported.
b
Log transformed data, geometric mean and approximate standard deviation reported.
c
Triglyceride data only available for some individuals (females n = 437, males n = 251). BMI = body mass index. HDL = high-density lipoprotein. JBS2 = Joint British Societies 2.